The American Cancer Society’s latest Cancer Statistics report reveals that the U.S. five-year survival rate for all cancers ...

Thousands of men with prostate cancer will be given a life-extending drug on the NHS, following a three-year battle to expand ...

Research from the University of Cambridge may be able to start a national screening programme for the common cancer ...

At the WCI Summit in November, researchers shared some of the novel techniques that they are using to improve the human ...

Jorge Manchola, a retired Air Force staff sergeant, was diagnosed with stage 4 lung cancer in 2023. The cancer had spread to his lungs and brain, leaving him in constant pain and unable to walk. FOX ...

A Sri Lankan-born scientist has made waves in the global medical community with groundbreaking research that could ...

Though the findings are positive overall, survival increases since the mid-1990s are especially notable for more fatal ...

Men with high‑risk locally advanced prostate cancer in England will soon be offered the drug abiraterone on the NHS, ...

Breakthrough Therapy Designation granted for investigational therapy IPN60340 in combination with venetoclax and azacitidine ...

Sevabertinib, targeting HER2 and EGFR mutations, received FDA breakthrough designation for HER2+ NSCLC, showing a 59% overall ...

Pancreatic cancer uses a sugar-coated disguise to evade the immune system, helping explain why it’s so hard to treat.

Seven in 10 people now survive their cancer five years or more, up from only half in the mid-70s,” said Rebecca Siegel, ...